Sumitomo Mitsui Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
9,608
+184
+2% +$23K 0.02% 90
2025
Q4
$64.4M Sell
9,424
-1,978
-17% -$227K 1.14% 15
2025
Q3
$1.14M Sell
11,402
-908
-7% -$81.8K 0.02% 87
2025
Q2
$1.02M Buy
12,310
+681
+6% +$54.3K 0.02% 88
2025
Q1
$943K Sell
11,629
-79
-0.7% -$7.06K 0.02% 90
2024
Q4
$1.05M Sell
11,708
-577
-5% -$55.9K 0.01% 91
2024
Q3
$1.21M Sell
12,285
-971
-7% -$95.4K 0.03% 88
2024
Q2
$1.23M Sell
13,256
-843
-6% -$75.6K 0.04% 88
2024
Q1
$1.34M Sell
14,099
-1,111
-7% -$103K 0.04% 89
2023
Q4
$1.36M Sell
15,210
-8,252
-35% -$613K 0.04% 81
2023
Q3
$1.71M Buy
23,462
+2,195
+10% +$175K 0.06% 80
2023
Q2
$1.77M Sell
21,267
-955
-4% -$79.9K 0.06% 81
2023
Q1
$1.69M Buy
22,222
+540
+2% +$44.8K 0.05% 89
2022
Q4
$1.8M Buy
21,682
+234
+1% +$18.9K 0.07% 87
2022
Q3
$1.7M Sell
21,448
-1,405
-6% -$118K 0.07% 98
2022
Q2
$1.7M Sell
22,853
-4,835
-17% -$363K 0.05% 114
2022
Q1
$2.49M Sell
27,688
-3,193
-10% -$295K 0.07% 102
2021
Q4
$3.46M Buy
30,881
+3,721
+14% +$449K 0.1% 82
2021
Q3
$3.41M Buy
27,160
+6,009
+28% +$774K 0.08% 87
2021
Q2
$2.86M Buy
21,151
+9,495
+81% +$1.25M 0.06% 83
2021
Q1
$1.58M Buy
11,656
+4,226
+57% +$633K 0.04% 91
2020
Q4
$1.05M Buy
7,430
+1,142
+18% +$146K 0.03% 96
2020
Q3
$701K Buy
6,288
+3,426
+120% +$384K 0.02% 97
2020
Q2
$320K Buy
2,862
+750
+36% +$73.9K 0.01% 99
2020
Q1
$164K Sell
2,112
-616
-23% -$54.5K 0.01% 113
2019
Q4
$259K Sell
2,728
-1,279
-32% -$111K 0.02% 98
2019
Q3
$306K Buy
4,007
+3,947
+6,578% +$328K 0.03% 88
2019
Q2
$5K Sell
60
-1,333
-96% -$114K ﹤0.01% 114
2019
Q1
$126K Sell
1,393
-1,282
-48% -$109K 0.01% 91
2018
Q4
$187K Hold
2,675
0.01% 91
2018
Q3
$256K Hold
2,675
0.02% 83
2018
Q2
$255K Buy
2,675
+2,296
+606% +$211K 0.03% 69
2018
Q1
$33K Buy
+379
New +$34.6K ﹤0.01% 109

Other funds holding XBI